China Pharma Holdings, Inc. (NYSE:CPHI)

Friday, November 15, 2019 | Web News
Third Quarter 2019 Financial Results Revenue increased by 3.4% to $2.4 million in the third quarter 2019 from $2.3 million in...
Thursday, August 15, 2019 | Web News
Second Quarter 2019 Financial Results Revenue decreased 19.0% to $2.6 million in the second quarter 2019 from $3.2 million in...
Wednesday, May 15, 2019 | Web News
First Quarter 2019 Financial Results Revenue decreased 19.0% to $2.9 million in the first quarter 2019 from $3.6 millionin the same...
See All Research...
China Pharma Holdings, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings. (press)

Web site: http://www.chinapharm.com.cn

Last updated March 28, 2008


Market Data powered by QuoteMedia. Terms of Use